CommentCancer: the elephant in the room
References (16)
- et al.
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
Lancet Oncol
(2012) An appeal to world leaders: stop cancer now
Lancet
(2013)- et al.
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Lancet
(2015) - et al.
A 50-year journey to cure childhood acute lymphoblastic leukemia
Semin Hematol
(2013) Cancer survival: global surveillance will stimulate health policy and improve equity
Lancet
(2014)- et al.
40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study
Lancet
(2015) Improving outcomes: a strategy for cancer
(2011)NHS launches new bid to beat cancer and save thousands of lives
There are more references available in the full text version of this article.
Cited by (12)
Antiproliferative 3-deoxysphingomyelin analogs: Design, synthesis, biological evaluation and molecular docking of pyrrolidine-based 3-deoxysphingomyelin analogs as anticancer agents
2019, Bioorganic ChemistryCitation Excerpt :Despite the achieved progress in understanding cancer biology, cancer still remains a difficult disease to treat and one of the leading causes of death all over the world [1,2].
Design, synthesis and cytotoxicity of chimeric erlotinib-alkylphospholipid hybrids
2019, Bioorganic ChemistryCitation Excerpt :Cancer is an arduous obstacle and a major cause for mortality in both developed and developing countries [1,2].
Addressing disparities in European cancer outcomes: a qualitative study Protocol of the BEACON project
2024, Frontiers in PsychologyGlobal Trends in Survival from Astrocytic Tumors in Adolescents and Young Adults: A Systematic Review
2021, JNCI Cancer Spectrum
Copyright © 2015 Elsevier Ltd. All rights reserved.